ライフサイエンスコーパス: nitric oxide production

1 h permeability edema), and nitrite/ nitrate (nitric oxide production).

2 nitrite/nitrate concentrations (a marker of nitric oxide production).

3 euronal nitric oxide synthase activation and nitric oxide production.

4 ilization of dysfunctional EPCs with blocked nitric oxide production.

5 ascular endothelial growth factor-stimulated nitric oxide production.

6 the increases were blocked by inhibitors of nitric oxide production.

7 be involved in the regulation of endothelial nitric oxide production.

8 se regulator function and is associated with nitric oxide production.

9 icant negative correlation between TCF11 and nitric oxide production.

10 al cofactor for catecholamine, serotonin and nitric oxide production.

11 s, in a dose-dependent manner, and triggered nitric oxide production.

12 nducing arginase I expression and inhibiting nitric oxide production.

13 igation by stimulating pulmonary endothelial nitric oxide production.

14 nvolved in acid resistance and inhibits host nitric oxide production.

15 tion of nuclear factor-kappaB activation and nitric oxide production.

16 COX-2 increases 4-HPR-induced apoptosis and nitric oxide production.

17 roxyphenyl)retinamide (4-HPR) by suppressing nitric oxide production.

18 -activated pathways, endotoxin tolerance, or nitric oxide production.

19 te interleukin-6 secretion but did not alter nitric oxide production.

20 nitric oxide synthase, leading to decreased nitric oxide production.

21 res, but to have no effect on LPS-stimulated nitric oxide production.

22 ects of LPS by inhibiting the stimulation of nitric oxide production.

23 h as proliferation, particle engulfment, and nitric oxide production.

24 sduction of ICSBP with IRF-1 clearly induces nitric oxide production.

25 ter Eph B4 stimulation, indicating increased nitric oxide production.

26 ed bone resorption in the presence of normal nitric oxide production.

27 oxide synthase from caveolae, and preventing nitric oxide production.

28 cytokine-stimulated granuloma formation and nitric oxide production.

29 nd IFN-gamma resulted in iNOS expression and nitric oxide production.

30 mal coupling of extracellular stimulation to nitric oxide production.

31 l recovery, which manifest as an increase in nitric oxide production.

32 iotensin system and inhibition of intrarenal nitric oxide production.

33 y IC + IFN-gamma-induced iNOS expression and nitric oxide production.

34 e, despite displaying a marked deficiency in nitric oxide production.

35 pha-melanocyte-stimulating hormone decreased nitric oxide production.

36 ducible nitric-oxide synthase expression and nitric oxide production.

37 er trauma-hemorrhage via endothelial derived nitric oxide production.

38 ascular resistance and disturbed endothelial nitric oxide production.

39 l immunity, gamma interferon production, and nitric oxide production.

40 compromised in their ability to downregulate nitric oxide production.

41 TGF-beta-induced proliferation and enhances nitric oxide production.

42 ation, reduced HO-1 expression and increased nitric oxide production.

43 re abolished by inhibition of either AMPK or nitric oxide production.

44 e from THP-1 cells as well as superoxide and nitric oxide production.

45 laxation of human and animal airways through nitric oxide production.

46 airway nerves as the source of TLR7-induced nitric oxide production.

47 on through nitric oxide synthase 2-dependent nitric oxide production.

48 re associated with HIF isoform regulation of nitric oxide production.

49 receptors and increase cytosolic Ca(2+) and nitric oxide production.

50 by limiting LDL oxidation via stimulation of nitric oxide production.

51 ide, but rather to suppression of macrophage nitric oxide production.

52 e effector response by increasing macrophage nitric oxide production.

53 ial nitric oxide synthase protein levels and nitric oxide production.

54 +/- 120.1 micromol/l, p = 0.003), decreased nitric oxide production (25.2 +/- 10.8 micromol/l to 22.

55 a stronger bactericidal activity with higher nitric oxide production, a more proinflammatory polarize

56 zed E(h) of Cys/CySS stimulated H2O2 but not nitric oxide production, activated nuclear factor-kappaB

57 cells, transduced with the genes to optimize nitric oxide production, adhered well to the pump surfac

58 play an essential role in the regulation of nitric oxide production after a septic challenge.

59 Differential regulation of nitric oxide production along the longitudinal and crypt

60 low-density lipoprotein reduces endothelial nitric oxide production (an important mediator of vasore

61 TMEV infection through preemptive antiviral nitric oxide production and antiviral STAT1 activation.

62 rom the internal store in endothelial cells, nitric oxide production and artery relaxation.

63 hosphorylation of eNOS, whereas it decreased nitric oxide production and bioactivity.

64 effect of soy isoflavone supplementation on nitric oxide production and blood pressure in menopausal

65 drial Ang system is coupled to mitochondrial nitric oxide production and can modulate respiration.

66 Tumor necrosis factor-alpha increased nitric oxide production and caused similar increase in S

67 MDSCs with ibrutinib significantly impaired nitric oxide production and cell migration.

68 The nitric oxide production and cytokine secretion in rat pe

69 ion of renal kallikrein expression increased nitric oxide production and dampened renal superoxide pr

70 Moreover, DATS restored nitric oxide production and decreased endothelial nitric

71 synthesis, restored cellular BH4 levels and nitric oxide production and decreased radiation-induced

72 Finally, HHcy potentiated HG-suppressed nitric oxide production and eNOS activity in HAECs, whic

73 important role in the regulation of iNOS and nitric oxide production and hence could account for some

74 ally ill patients with sepsis have increased nitric oxide production and increased bone resorption, w

75 ed in a significant decrease in MCAO-induced nitric oxide production and inducible nitric-oxide synth

76 Th1 cells, but not Th2 cells, induced nitric oxide production and inhibited intracellular para

77 ibited LPS- and IFN-gamma-induced macrophage nitric oxide production and iNOS mRNA accumulation.

78 nt macrophages, stimulating iNOS expression, nitric oxide production and interleukin-1 (IL-1) release

79 This cascade requires prostanoid/nitric oxide production and is independent of Wnt/LRP5.

80 ability to activate macrophages in vitro for nitric oxide production and killing of Leishmania major

81 soy isoflavone supplementation to stimulate nitric oxide production and lower blood pressure in meno

82 ormal vascular function via endothelial cell nitric oxide production and modulation of Ca(2+) handlin

83 Limb nitric oxide production and muscle phospho-endothelial n

84 Inhibitors of nitric oxide production and of SNO blocked PAF-induced S

85 features of microglial activation including nitric oxide production and phagocytosis.

86 ssociated with increased iNOS expression and nitric oxide production and prevented by L-NIO, an enzym

87 ave found reductions of basal and stimulated nitric oxide production and responses to exogenous nitri

88 Insights into mechanisms regulating nitric oxide production and signaling and their integrat

89 response requires protein kinase A-dependent nitric oxide production and subsequent PAK2 phosphorylat

90 nostic tests, including measurement of nasal nitric oxide production and systematic analysis for muta

91 eprived motor neuron survival by suppressing nitric oxide production and the consequent peroxynitrite

92 ilar to estrogens, are believed to stimulate nitric oxide production and thus lower blood pressure.

93 ophages prevented LPS-induced growth arrest, nitric oxide production and TNF-alpha secretion by ANA-1

94 nitric oxide synthase (iNOS) expression and nitric oxide production and to inhibit beta cell functio

95 antagonist, anakinra, efficiently decreased nitric oxide production and vascular proliferation and r

96 s hypertension and atherosclerosis, in which nitric oxide production and/or biological activity is im

97 duced increase in urinary nitrates/nitrites (nitric oxide production) and 8-isoprostane (oxidative st

98 (CPSI, related to urea cycle and endogenous nitric oxide production) and complement factor H-related

99 ated protein product has defects in folding, nitric oxide production, and binding of cofactors.

100 nteractions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leu

101 ibit increased gamma interferon (IFN-gamma), nitric oxide production, and delayed-type hypersensitivi

102 resulted in impaired fungicidal ability, low nitric oxide production, and elevated synthesis of inter

103 etermining organism survival, superoxide and nitric oxide production, and expression of the cytokines

104 ndothelial nitric oxide synthase expression, nitric oxide production, and heme oxygenase-1 (HO-1) exp

105 F + LPS + IFN-gamma-induced iNOS expression, nitric oxide production, and IL-1 mRNA expression by hum

106 nitric oxide synthase uncoupling, decreased nitric oxide production, and increased superoxide genera

107 essed by proliferation rate, apoptosis rate, nitric oxide production, and inflammatory markers TNF-al

108 II (inducible) nitric oxide synthase (iNOS), nitric oxide production, and inhibition of DNA synthesis

109 ble nitric oxide synthase (iNOS) expression, nitric oxide production, and inhibits glucose-stimulated

110 rditis virus (EMCV)-induced iNOS expression, nitric oxide production, and iPLA2 enzymatic activity in

111 's anti-Plasmodium defense as a substrate of nitric oxide production, and its availability therefore

112 ltures, and gene expression, collagenase and nitric oxide production, and NF-kappaB activation were d

113 otein kinase C translocation and activation, nitric oxide production, and nitric oxide-activated poly

114 Total leukocyte counts, myeloperoxidase, nitric oxide production, and proteins were all significa

115 loperoxidase activity and total cell counts, nitric oxide production, and proteins.

116 otaxis, endothelial inflammation, oxidation, nitric oxide production, and thrombosis reveal other dim

117 that high doses of nonspecific inhibitors of nitric oxide production are contraindicated in septic sh

118 uced energy deficiency, and (ii) the role of nitric oxide production as a potential mechanism for ene

119 s, and considerable evidence points to local nitric oxide production as an important but complex regu

120 activate macrophage NF-kappa B signaling and nitric oxide production, as well as the MAP kinase p38,

121 rn, Northern, and Western blot analysis, and nitric oxide production assays.

122 ile there can be detrimental consequences of nitric oxide production at pathological concentrations,

123 the TLR7 antagonist IRS661 and by inhibiting nitric oxide production but not by inhibiting prostaglan

124 ucible nitric oxide synthase, also increased nitric oxide production but this response was reduced by

125 ent of zinc deficiency-induced intracellular nitric oxide production but was attenuated by the additi

126 is dependent on NMDA receptor activation and nitric oxide production, but little else is known about

127 ing pathway is not involved in TNF-alpha and nitric oxide production, but, interestingly, negatively

128 Inhibition of nitric oxide production by activated macrophages by usin

129 using the Limulus amebocyte lysate assay and nitric oxide production by alveolar macrophage.

130 sors have been used to measure extracellular nitric oxide production by BALB/c mouse macrophages.

131 Nitric oxide production by cells subjected to pulsatile

132 Nitric oxide production by cultured cells was measured e

133 AM stimulates nitric oxide production by endothelial cells, whereas PA

134 localization of eNOS is required for optimal nitric oxide production by endothelial cells.

135 Deficits in nitric oxide production by endothelial nitric oxide synt

136 This was associated with reduced nitric oxide production by hepatocytes.

137 te-macrophage colony-stimulating factor] and nitric oxide production by human and murine monocyte/mac

138 I-C) + IFN-gamma-induced iNOS expression and nitric oxide production by human islets are prevented by

139 Gram-negative bacteria induces cytokine and nitric oxide production by inflammatory cell types.

140 that lipopolysaccharide increases medullary nitric oxide production by iNOS induction, resulting in

141 in complement-mediated phagocytosis, inhibit nitric oxide production by macrophage-like cells, protec

142 IFN-gamma fails to induce iNOS expression or nitric oxide production by macrophages isolated from IRF

143 I isozymes, participate in the regulation of nitric oxide production by modulating the availability o

144 A + IFN-gamma-stimulated iNOS expression and nitric oxide production by mouse islets.

145 sRNA + IFN-gamma-induced iNOS expression and nitric oxide production by mouse peritoneal macrophages

146 Nitric oxide production by pex cells was dependent upon

147 nitric oxide synthase (iNOS) expression and nitric oxide production by rat, mouse, and human islets.

148 NOS-dependent nitric oxide production by S. scabies was also reduced i

149 arinic and nicotinic receptor activation and nitric oxide production by using immunocytochemistry for

150 Nitric oxide production by various routes was sufficient

151 Estrogen receptor regulation of nitric oxide production by vascular endothelium may invo

152 Inhibition of protein synthesis, nitric oxide production, Ca2+ entry into cells, and pert

153 ietary supplementation aimed to increase the nitric oxide production can also be beneficial.

154 Thus, differences in nitric oxide production cannot account for the different

155 guanosine 3', 5'-monophosphate, an index of nitric oxide production, compared with WT mice.

156 Previous studies have suggested that loss of nitric oxide production contributes to these changes.

157 onstitutive iNOS expression and, implicitly, nitric oxide production, contributing to the poor surviv

158 s evidence suggesting that the inhibition of nitric oxide production could be a desirable future ther

159 trogen receptor (ER)-mediated stimulation of nitric oxide production, demonstrated by preinjecting th

160 Elevated nitric oxide production did not occur after FAK depletio

161 Inhibition of nitric oxide production did not significantly affect the

162 Nitric oxide production doubles within 10 min exposure t

163 is important for developing ways to control nitric oxide production during angiogenesis and in many

164 NNFC caused a progressive drop in nitric oxide production during flow cessation followed b

165 Blocking CX3CR1 or nitric oxide production during G-CSF treatment reduces e

166 chemokine expression, cell recruitment, and nitric oxide production during primary LVS infection and

167 g either CD23 upregulation or CD23-dependent nitric oxide production eliminated the enhanced antifung

168 had no effect, and inhibition of endogenous nitric oxide production failed to increase TF expression

169 s fast responses and an initial overshoot of nitric oxide production for given doses of TNF and IFN-g

170 72 h was shown to dose-dependently increase nitric oxide production from 6-day-old retinal cultures.

171 , which were consistently unable to suppress nitric oxide production from activated macrophages.

172 Nitric oxide production from AMs of HHCs increased on Da

173 have indicated the importance of sufficient nitric oxide production from arginine during normal frac

174 In rat cerebellar slices, we activated nitric oxide production from each isoform of nitric oxid

175 Under proatherogenic conditions, nitric oxide production from endothelial cells is reduce

176 ectoenzyme on T cells, controls the rate of nitric oxide production from GSNO and thus markedly affe

177 However, to our knowledge, evidence of nitric oxide production from HU metabolism in humans has

178 se-mediated pathway as a potential source of nitric oxide production from hydroxyurea.

179 These results demonstrate nitric oxide production from the ferric catalase oxidati

180 ium influx, tumor necrosis factor-alpha, and nitric oxide production in a concentration-dependent man

181 rasite Toxoplasma gondii is able to suppress nitric oxide production in activated macrophages.

182 herapy also significantly increased vascular nitric oxide production in apoE(-/-) mice.

183 -SP1 induced the ability of MSP-1 to inhibit nitric oxide production in bone marrow macrophages.

184 Cytokines stimulate nitric oxide production in bone, and high concentrations

185 ble nitric oxide synthase and stimulation of nitric oxide production in chondrocytes by octacalcium p

186 mor growth assays reveal that Notch-mediated nitric oxide production in endothelial cell requires VEG

187 This study uncovers a novel mechanism of nitric oxide production in endothelial cells in tumors,

188 importance, shear stress does not stimulate nitric oxide production in endothelial cells on fibronec

189 RBC-derived ATP, which is known to stimulate nitric oxide production in endothelial cells, resulting

190 In addition, it stimulates nitric oxide production in endothelial cells, which may

191 ylcooxygenases (COX-1 and COX-2), aromatase, nitric oxide production in endotoxin-stimulated macropha

192 ases in interleukin-8, GRO-alpha, MCP-1, and nitric oxide production in HeLa and AGS cells, despite s

193 ctive effect of copper depends on endogenous nitric oxide production in hippocampal neurons, demonstr

194 educed by 30% cytokine-induced apoptosis and nitric oxide production in INS-1E cells.

195 rk form the basis for real-time detection of nitric oxide production in living cells.

196 proinflammatory cytokines and suppression of nitric oxide production in macrophages.

197 pha-melanocyte-stimulating hormone regulates nitric oxide production in melanocytic cells by modulati

198 Nitric oxide production in murine J774A.1 cells, as well

199 hVEGF-B induced nitric oxide production in NP macrophages (P < 0.05).

200 nefitted from (1) documentation of low nasal nitric oxide production in PCD and (2) discovery of bial

201 s work is to demonstrate that RBCs stimulate nitric oxide production in platelets by employing a cont

202 tion of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells.

203 anticoronavirus activity, and suppression of nitric oxide production in RAW264.7 cells (a measure of

204 hanisms that induce TIMSC and the effects on nitric oxide production in response to endotoxin.

205 n vitro TNF-alpha, interleukin 6 (IL-6), and nitric oxide production in response to LPS.

206 ed by arterial endothelial cells, especially nitric oxide production in response to physiologic stimu

207 Enhanced nitric oxide production in sepsis is related to suggeste

208 nitric oxide synthase inhibitor to decrease nitric oxide production in septic shock.

209 MnSOD siRNA also reduced nitric oxide production in supernatants of IPAH-ECs.

210 ain and prevented nerve injury-evoked excess nitric oxide production in the DRG, whereas administerin

211 Nitric oxide production in the grafts was increased by C

212 anisms of altered myocyte function caused by nitric oxide production in this setting are not establis

213 dothelial cell proliferation, migration, and nitric oxide production in vitro and increased expressio

214 creased inflammatory responses and increased nitric oxide production in vitro in response to Salmonel

215 dothelial nitric oxide synthase activity and nitric oxide production, increased aortic cyclooxygenase

216 oglia exposed to 15-30 microm zinc increased nitric oxide production, increased F4/80 expression, alt

217 and Ca(2+) influx, which activates low-level nitric oxide production, increases apical membrane Cl(-)

218 n the iNOS gene promoter activity and on the nitric oxide production induced by LPS and IFN-gamma.

219 n; the finding that inhibiting superoxide or nitric oxide production inhibits both peroxynitrite prod

220 Inhibition of strain-related prostanoid and nitric oxide production inhibits strain-related (and bas

221 Mechanical strain suppressed nitric oxide production, iNOS mRNA, and iNOS protein sti

222 unctional analysis revealed that endothelial nitric oxide production is decreased by Notch inhibition

223 that MyD88- and Card9-mediated IFN-gamma and nitric oxide production is essential for protection agai

224 ible nitric oxide synthase, in which ROS and nitric oxide production is greatly decreased; (iii) a kn

225 ed association with actin filaments but peak nitric oxide production is transient due to actin S-nitr

226 lial dysfunction, characterized by decreased nitric oxide production, is one of the early features in

227 that arginase activity, which inhibits host nitric oxide production, is post-translationally stimula

228 ent increases in reactive oxygen species and nitric oxide production leading to increased caspase 3 a

229 pression profiles, oxygen consumption rates, nitric oxide production levels, shear stress responses,

230 s are associated with improper regulation of nitric oxide production, making NOS a therapeutic target

231 Our data indicate that tumor-associated nitric oxide production may promote cancer progression b

232 ric oxide synthase--the gene responsible for nitric oxide production--may be affected by air pollutan

233 The resulting increase in nitric-oxide production might be critical to the atherop

234 elerated calcium influx (n = 9) and enhanced nitric oxide production (n = 12) (vs four and eight cont

235 ue to defective oxidative phosphorylation or nitric oxide production), Na+ influx through voltage-gat

236 systemic hypertension or changes in cerebral nitric oxide production needs to be evaluated.

237 -X(L) in the regulation of cytosolic Ca(2+), nitric oxide production (NO), c-Jun NH(2)-terminal kinas

238 transport and ii) fluid shear stress induced nitric oxide production (NO).

239 iazen-1- ium-1,2-diolate [DETA-NO]) or block nitric oxide production (Nomega-methyl-L-arginine [L-NMA

240 Inhibiting nitric oxide production (Nomega-nitro-L-arginine, 50 mic

241 lin were analyzed for iNOS up-regulation and nitric oxide production (NOx) in the presence of various

242 thelial nitric oxide synthase contributed to nitric oxide production, only inducible nitric oxide syn

243 he differences appear to be due to defective nitric oxide production or bioavailability and might exp

244 ot activate macrophage NF-kappa B signaling, nitric oxide production or inducible nitric-oxide syntha

245 tivation of NF-kappaB, but it did not affect nitric oxide production or iNOS gene expression.

246 Mitochondrial inhibition did not affect nitric oxide production or MAP kinase phosphorylation, w

247 M N(omega)-nitro-L-arginine (LNNA) to block nitric oxide production, or 10(-5) M glibenclamide to bl

248 t dsRNA + IFN-gamma-induced iNOS expression, nitric oxide production, or the inhibitory actions of th

249 dothelial sodium channel activation, reduced nitric oxide production, oxidative stress, and inflammat

250 mmune splenocyte population markedly reduced nitric oxide production, prevented suppression of PFC re

251 ealthy children, HDL(CKD) strongly inhibited nitric oxide production, promoted superoxide production,

252 Inhibition of local Nitric Oxide production reduced firing rates but did not

253 a demonstrate that differential flow-induced nitric oxide production regulates matrix-specific PAK si

254 ry network to modulate adaptive immunity via nitric oxide production, reminiscent of the monocytic su

255 deprivation can be attributed to diminished nitric oxide production resulting from the activity of t

256 e MEK/ERK pathway potentiates LPS-stimulated nitric oxide production, suggesting that LPS-stimulated

257 carrying mutant p53 and that a high level of nitric oxide production suppresses tumor growth and meta

258 ne stimulation in these cells also activated nitric oxide production that was blocked by sigma1-recep

259 ities (tubule formation, cell migration, and nitric oxide production) that were mediated by rcav-1 st

260 ages may determine the rate and magnitude of nitric oxide production, thereby regulating the cytotoxi

261 ut (KO) mice, indicating that the absence of nitric oxide production through iNOS is not compensated

262 ndothelial cells, PTX3 significantly blunted nitric oxide production through the matrix metalloprotei

263 lcium signals in primary cells that activate nitric oxide production to increase ciliary beating and

264 epleted immune cells with IFN-gamma restored nitric oxide production to levels comparable to those of

265 sRNA + IFN-gamma induces iNOS expression and nitric oxide production to similar levels by macrophages

266 ssembly of supramolecular complexes coupling nitric oxide production to upstream and downstream compo

267 hrough its regulation of eNOS expression and nitric oxide production to vascular hyperpermeability an

268 ant induction of reactive oxygen species and nitric oxide production trigger marrow vessel leakiness,

269 endently confirmed by an increase in myocyte nitric oxide production upon extracellular application o

270 ell-induced immunosuppression is mediated by nitric oxide production via inducible nitric oxide synth

271 Nitric oxide production was assessed by measuring the ra

272 ur previous studies showed that T/HS-induced nitric oxide production was associated with lung injury,

273 Furthermore, renal nitric oxide production was decreased, and homogenates f

274 s cultured on more compliant substrates, and nitric oxide production was enhanced.

275 Splenic nitric oxide production was impaired in infected memTNF

276 Basal nitric oxide production was increased and endothelial ni

277 The tested doses showed that nitric oxide production was inhibited by L-NMMA in canin

278 Finally, inhibition of nitric oxide production was lethal, indicating that high

279 Nitric oxide production was measured by Griess reaction,

280 Nitric oxide production was measured by the Griess react

281 TLR7-mediated nitric oxide production was measured using a fluorescent

282 Furthermore, nitric oxide production was prevented and, more importan

283 To determine whether altered nitric oxide production was responsible, plasma nitrite

284 ducible nitric oxide synthase expression and nitric oxide production was severely impaired in the INS

285 Nasal nitric oxide production was very low in PCD (nl/minute;

286 ell lysis would be detrimental to epithelial nitric oxide production we hypothesized that perforin wa

287 els, cytokine levels, eicanosoid levels, and nitric oxide production were compared between strains.

288 Cell proliferation rate and nitric oxide production were increased and apoptosis rat

289 Both Limulus amebocyte lysate activity and nitric oxide production were related to the degree of op

290 We further revealed that IL-6 and nitric oxide production were significantly higher by wil

291 nction and endothelial dependent relaxation (nitric oxide production) were determined using an organ

292 ate dehydrogenase membrane leakage assay and nitric oxide production, were used to determine if these

293 -induced activity of the HRE is dependent on nitric oxide production, which acts as a diffusible para

294 tis virus (EMCV) induces iNOS expression and nitric oxide production, which are unaffected by a domin

295 Moreover, endothelial stiffening reduces nitric oxide production, which promotes smooth muscle ce

296 and 23 mo) to characterize changes in renal nitric oxide production with age.

297 nti-TGF-beta treatment resulted in increased nitric oxide production within parasitized lesions.

298 function by increasing arginase activity and nitric oxide production, without affecting reactive oxyg

299 Reduction of HAP through inhibition of nitric oxide production worsened the recovery from FHVOO

300 eatment showed no effects on tube formation, nitric oxide production, wound healing or cell prolifera